Transcanna Holdings Inc (TCAN.CX)
0.01
0.00 (0.00%)
CAD |
CNSX |
May 07, 16:00
Transcanna Holdings Revenue (Quarterly): 0.6841M for Aug. 31, 2022
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2022 | 0.6841M |
| May 31, 2022 | 0.9208M |
| February 28, 2022 | 0.5854M |
| November 30, 2021 | 1.698M |
| August 31, 2021 | 0.9751M |
| May 31, 2021 | 0.7342M |
| Date | Value |
|---|---|
| February 28, 2021 | 0.5914M |
| November 30, 2020 | 0.7015M |
| August 31, 2020 | 1.796M |
| May 31, 2020 | 3.562M |
| February 29, 2020 | 0.9058M |
| November 30, 2019 | 0.2405M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.2405M
Minimum
Nov 2019
3.562M
Maximum
May 2020
1.116M
Average
0.82M
Median
Revenue (Quarterly) Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | 0.0937M |
| Nova Mentis Life Science Corp | 0.0283M |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | 0.1362M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.317M |
| Total Expenses (Quarterly) | 2.121M |
| EPS Diluted (Quarterly) | -0.04 |